Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

18 Jul 2023 07:00

RNS Number : 2908G
Kingspan Group PLC
17 July 2023
 

 

Kingspan Group plc

 

Acquisition

 

Inside Information

 

17 July 2023

 

Kingspan Group plc ("Kingspan") announces the acquisition of a majority stake in Steico SE

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, is pleased to announce that it has entered into an agreement with Schramek GmbH ("Schramek") to acquire c.51% of the shares of Steico SE ("Steico"), with an option to acquire a further c.10% of shares in Steico in the future.

 

Steico is the world leader in natural insulation and wood-based building envelope products, based in Germany and listed on the unofficial markets of several German Stock Exchanges. It has a very well invested asset base, with four large production sites comprising 27 lines situated in Poland and France, including additional capacity nearing completion with up to EUR200m revenue headroom.

 

Steico had audited operating revenues of EUR445m in the 12 months to 31 December 2022 and EBITDA of EUR90m in the same period. As at June 2023, Steico guided 2023 revenues of c.EUR378m at an EBIT margin of 8% - 10% (FY22 14.6%). As at 31 December 2022, Steico had gross assets of EUR509m.

 

The initial consideration for the shares will be EUR35 per share, plus potential deferred consideration of up to a further EUR35 per share contingent on achievement of specified thresholds with a material uplift in profitability. The initial consideration of approximately EUR251.4m will be satisfied on completion, with 25% of the consideration potentially being exchanged for new shares in Kingspan (subject to Kingspan share price at completion). The consideration payable under the put and call option to acquire Schramek's remaining c. 10% in Steico is for a capped amount based on a multiple of future earnings.

The acquisition is expected to be earnings neutral initially, based on Kingspan consensus EPS for 2023 and Steico guidance for 2023.

 

In addition to Steico's existing ambitious growth plans we anticipate significant long term leverage via the Kingspan sales channels. The existing Steico executive management team will be retained in the business, and will continue to manage and develop the business. Upon closing, Kingspan will seek fair representation on Steico's administrative board.

 

The acquisition is conditional on regulatory clearance, and is expected to complete in early 2024. Following completion, Steico will continue to maintain its listings on the German Stock Exchanges.

 

 

Gene Murtagh, Kingspan Chief Executive Officer, commented:

 

"The acquisition of a majority stake in Steico represents an exciting next step in our strategy to provide the full spectrum of insulation products. Its suite of wood-based building envelope solutions broadens our ability to enable our customers to meet their sustainability and energy performance needs. Kingspan's global routes to market, paired with our drive to innovate and widen the applications of Steico's current technologies, are key to our plans to bring Steico bio-based solutions to the next level."

 

Udo Schramek, Steico Chief Executive Officer, stated:

 

"It has been a great honour to lead the team at Steico to become the pre-eminent global supplier of wood-based insulation. We are now entering the next phase of growth and are very enthusiastic about the collaboration opportunities Kingspan brings, in both the existing Steico range and across the Kingspan portfolio and geographies. I am excited about the future for Steico and about being invested in the future growth of both companies."

 

 

Kingspan will hold an investor call at 8.30am IST on Tuesday 18 July 2023 to discuss the acquisition.

 

Operator Assisted Dial-In: United Kingdom (Local): +44 20 4587 0498 United Kingdom (Toll-Free): +44 800 358 1035 Access Code: 022503

 

Further call details will be available shortly on the Investor Relations section of our website www.kingspangroup.com. A recording of this conference call will be made available. For further information about the conference call please contact: ir@kingspan.com or +353 (0)42 969 8000.

 

 

Lorcan Dowd

Company Secretary

+ 353 (0)42 9698000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAPXXFDXDEFA
Date   Source Headline
5th Apr 202212:49 pmRNSHolding(s) in Company
4th Apr 20229:51 amRNSHolding(s) in Company
1st Apr 20229:00 amRNSTotal Voting Rights
1st Apr 20227:00 amRNSHolding(s) in Company
30th Mar 20223:55 pmRNSDirector/PDMR Shareholding
28th Mar 20229:32 amRNSHolding(s) in Company
24th Mar 20226:09 pmRNSHolding(s) in Company
21st Mar 202212:00 pmRNSNotice of AGM
7th Mar 20226:06 pmRNSHolding(s) in Company
1st Mar 20227:00 amRNSTotal Voting Rights
24th Feb 20222:35 pmRNSDirector/PDMR Shareholding
24th Feb 20228:34 amRNSAnnual Financial Report
23rd Feb 20223:56 pmRNSDirector/PDMR Shareholding
18th Feb 20227:00 amRNSAcquisition
18th Feb 20227:00 amRNSFinal Results
27th Jan 20226:10 pmRNSHolding(s) in Company
27th Jan 20229:34 amRNSHolding(s) in Company
12th Jan 20225:01 pmRNSHolding(s) in Company
10th Jan 20223:22 pmRNSHolding(s) in Company
4th Jan 20229:00 amRNSBlock listing Interim Review
4th Jan 20228:00 amRNSTotal Voting Rights
9th Dec 202110:56 amRNSHolding(s) in Company
7th Dec 20214:15 pmRNSHolding(s) in Company
7th Dec 20219:17 amRNSHolding(s) in Company
1st Dec 20214:48 pmRNSTotal Voting Rights
22nd Nov 202110:14 amRNSHolding(s) in Company
8th Nov 20217:00 amRNSTrading Statement
1st Nov 20213:45 pmRNSTotal Voting Rights
6th Oct 202110:38 amRNSHolding(s) in Company
1st Oct 202111:17 amRNSTotal Voting Rights
1st Oct 202110:04 amRNSDirector Declaration
1st Oct 20219:23 amRNSHolding(s) in Company
10th Sep 20211:54 pmRNSDirector/PDMR Shareholding
8th Sep 20212:12 pmRNSDirector/PDMR Shareholding
1st Sep 202110:22 amRNSTotal Voting Rights
24th Aug 20212:49 pmRNSHolding(s) in Company
23rd Aug 20212:48 pmRNSDirector/PDMR Shareholding
20th Aug 20217:00 amRNSHalf-year Report
16th Aug 20219:53 amRNSHolding(s) in Company
22nd Jul 202110:42 amRNSHolding(s) in Company
7th Jul 20214:53 pmRNSHolding(s) in Company
6th Jul 20215:14 pmRNSHolding(s) in Company
6th Jul 20215:12 pmRNSHolding(s) in Company
1st Jul 202111:44 amRNSBlock listing Interim Review
1st Jul 202111:36 amRNSTotal Voting Rights
23rd Jun 20215:12 pmRNSHolding(s) in Company
22nd Jun 20217:00 amRNSTrading Statement
15th Jun 202112:49 pmRNSAcquisition Update
11th Jun 20216:36 pmRNSHolding(s) in Company
10th Jun 20215:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.